Mode Diagnostics

About:

Mode Diagnostics is exploiting the electrochemical properties of biomarkers to produce novel assays for home diagnostic purposes.

Website: http://www.modehealth.com

Top Investors: Parkwalk Advisors

Description:

Mode Diagnostics is exploiting the electrochemical properties of biomarkers to produce novel assays for home diagnostic purposes. The company has developed a suite of technologies comprising assay development techniques, biosensing capabilities, microfabrication, electronics and wireless communications. MODE is an innovative product development company rapidly building a pipeline of user friendly and medically informative health screening products specifically designed for the Physicians office and consumer self-testing. MODE’s proprietary platform – measure – is a flexible, low-cost and hygenic platform that can easily be configured to create health tests for both the Physicians Office and Consumer self-testing. MODE’s first product, measure BOWEL HEALTH represents an evolution in bowel cancer screening (faceal occult blood) offering significant improvements over the current testing methods.

Total Funding Amount:

1.7M GBP

Headquarters Location:

Glasgow, Glasgow City, United Kingdom

Founded Date:

2007-01-01

Contact Email:

info(AT)modehealth.com

Founders:

Paul Heaney

Number of Employees:

1-10

Last Funding Date:

2014-01-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai